Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh
Ashraf H, Beglinger C, Hassan M, Salam M, Hossain L, Bardhan P, Brooks A, Rothermundt C, Alam N, Gyr N. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infect Dis 2010; 10:208.
15.07.2010Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh
15.07.2010BMC Infect Dis 2010; 10:208
Ashraf Hasan, Beglinger Christoph, Hassan Mohammed S, Salam Mohammed A, Hossain Lokman, Bardhan Pradip, Brooks Abdullah, Rothermundt Christian, Alam Nur H, Gyr Niklaus
Metastasiertes Prostatakarzinom – Behandlungsmöglichkeiten nach der Hormontherapie
Omlin A, Kaelin M, Templeton A, Jungi M, Gillessen Sommer S, Graf H, Rothermundt C. Metastasiertes Prostatakarzinom – Behandlungsmöglichkeiten nach der Hormontherapie. Swiss Medical Forum 2010; 10:483-485.
14.07.2010Metastasiertes Prostatakarzinom – Behandlungsmöglichkeiten nach der Hormontherapie
14.07.2010Swiss Medical Forum 2010; 10:483-485
Omlin Aurelius, Kaelin Martin, Templeton Arnoud, Jungi Manuel, Gillessen Sommer Silke, Graf Hans-Jörg, Rothermundt Christian
Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?
Buikhuisen W, Burgers J, Vincent A, Schellens J, Beijnen J, Smit E, Jörger M. Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?. J Clin Oncol 2010; 28:e482-3; author reply e484.
06.07.2010Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?
06.07.2010J Clin Oncol 2010; 28:e482-3; author reply e484
Buikhuisen Wieneke A, Burgers Jacobus A, Vincent Andrew D, Schellens Jan H M, Beijnen Jos H, Smit Egbert F, Jörger Markus
Long-term renal safety profile of ibandronate 6 mg infused over 15 minutes
von Moos R, Caspar C, Steiner R, Angst R, Inauen R, Schmieding K, Thürlimann B. Long-term renal safety profile of ibandronate 6 mg infused over 15 minutes. Onkologie 2010; 33:447-50.
06.07.2010Long-term renal safety profile of ibandronate 6 mg infused over 15 minutes
06.07.2010Onkologie 2010; 33:447-50
von Moos Roger, Caspar Clemens B, Steiner Rolf, Angst Rahel, Inauen Roman, Schmieding Kerstin, Thürlimann Beat
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
Rochlitz C, Zaman K, Mayer M, Cliffe B, Herrmann R, Mannhart-Harms M, Muller A, Rauch D, Winterhalder R, von Moos R, Schonenberger A, Fehr M, Bühlmann M, Suter T, Huober J, Spirig C, Lerch S, Ruhstaller T, Swiss Group for Clinical Cancer Research (SAKK). Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06). Ann Oncol 2010; 22:80-5.
01.07.2010Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
01.07.2010Ann Oncol 2010; 22:80-5
Rochlitz C, Zaman K, Mayer M, Cliffe B, Herrmann R, Mannhart-Harms M, Muller A, Rauch D, Winterhalder R, von Moos R, Schonenberger A, Fehr M, Bühlmann M, Suter T, Huober Jens, Spirig C, Lerch S, Ruhstaller Thomas, Swiss Group for Clinical Cancer Research (SAKK)
Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort
Cathomas R, De Santis M, Beyer J, Mayer F, Lorch A, Zaugg K, Seifert H, Shahin O, Rentsch C, Rothermundt C, Stenner F, Helbling D, Gillessen Sommer S. Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort. Swiss Med Wkly 2010; 140:356-69.
26.06.2010Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort
26.06.2010Swiss Med Wkly 2010; 140:356-69
Cathomas Richard, De Santis Maria, Beyer Jörg, Mayer Frank, Lorch Anja, Zaugg Kathrin, Seifert Hans-Helge, Shahin Osama, Rentsch Cyrill, Rothermundt Christian, Stenner Frank, Helbling Daniel, Gillessen Sommer Silke
Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment?
Jörger M, Thürlimann B, Huober J. Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment?. Ann Oncol 2010; 22:17-23.
20.06.2010Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment?
20.06.2010Ann Oncol 2010; 22:17-23
Jörger Markus, Thürlimann Beat, Huober Jens
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study
Moebus V, Konecny G, Kreienberg R, Hinke A, Runnebaum I, von Minckwitz G, Harbeck N, Huober J, Schneeweiss A, Nitz U, Kuhn W, Kurbacher C, Thomssen C, du Bois A, Lueck H, Jackisch C, Untch M. Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study. J Clin Oncol 2010; 28:2874-80.
10.06.2010Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study
10.06.2010J Clin Oncol 2010; 28:2874-80
Moebus Volker, Konecny Gottfried E, Kreienberg Rolf, Hinke Axel, Runnebaum Ingo B, von Minckwitz Gunter, Harbeck Nadia, Huober Jens, Schneeweiss Andreas, Nitz Ulrike, Kuhn Walther, Kurbacher Christian, Thomssen Christoph, du Bois Andreas, Lueck Hans-Joachim, Jackisch Christian, Untch Michael
Brustzentrum Kantonsspital St. Gallen – von der Multidisziplinarität zur patientinnenzentrierten interdisziplinären Betriebsorganisation
Baumann M, Thürlimann B, Ruhstaller T. Brustzentrum Kantonsspital St. Gallen – von der Multidisziplinarität zur patientinnenzentrierten interdisziplinären Betriebsorganisation. Breast Care 2010; 5:188-191.
08.06.2010Brustzentrum Kantonsspital St. Gallen – von der Multidisziplinarität zur patientinnenzentrierten interdisziplinären Betriebsorganisation
08.06.2010Breast Care 2010; 5:188-191
Baumann Michael, Thürlimann Beat, Ruhstaller Thomas
Adjuvant Cisplatin-Based Chemotherapy for Elderly
Früh M, Shepherd F. Adjuvant Cisplatin-Based Chemotherapy for Elderly. EUROPEAN JOURNAL OF CLINICAL & MEDICAL ONCOLOGY 2010:59-63.
06.06.2010Adjuvant Cisplatin-Based Chemotherapy for Elderly
06.06.2010EUROPEAN JOURNAL OF CLINICAL & MEDICAL ONCOLOGY 2010:59-63
Früh Martin, Shepherd Frances
Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
Böhm S, Hess D, Gillessen Sommer S, Brändle M. Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib. Diabetes care 2010; 33:e82.
01.06.2010Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
01.06.2010Diabetes care 2010; 33:e82
Böhm Steffen, Hess Dagmar, Gillessen Sommer Silke, Brändle Michael
Effect of the 50-hour workweek limitation on training of surgical residents in Switzerland
Businger A, Gueller U, Oertli D. Effect of the 50-hour workweek limitation on training of surgical residents in Switzerland. Arch Surg 2010; 145:558-63.
01.06.2010Effect of the 50-hour workweek limitation on training of surgical residents in Switzerland
01.06.2010Arch Surg 2010; 145:558-63
Businger Adrian, Gueller Ulrich, Oertli Daniel
Population-based trend analysis of laparoscopic Nissen and Toupet fundoplications for gastroesophageal reflux disease
Zingg U, Rosella L, Gueller U. Population-based trend analysis of laparoscopic Nissen and Toupet fundoplications for gastroesophageal reflux disease. Surg Endosc 2010; 24:3080-5.
13.05.2010Population-based trend analysis of laparoscopic Nissen and Toupet fundoplications for gastroesophageal reflux disease
13.05.2010Surg Endosc 2010; 24:3080-5
Zingg U, Rosella L, Gueller Ulrich
Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.
Halter J, Schüpbach W, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann T, Mandel H, Martinez R, Mattle H, Orchard K, Savage D, Sue C, Valcarcel D, Gratwohl A, Hirano M. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 2010; 46:330-337.
03.05.2010Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.
03.05.2010Bone Marrow Transplant 2010; 46:330-337
Halter J, Schüpbach Wmm, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann Thomas, Mandel H, Martinez Raquel, Mattle Heinrich P, Orchard K, Savage David B, Sue C M, Valcarcel D, Gratwohl A, Hirano M
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D'Addario G, Früh M, Reck M, Baumann P, Klepetko W, Felip E, ESMO Guidelines Working Group. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 Suppl 5:v116-9.
01.05.2010Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
01.05.2010Ann Oncol 2010; 21 Suppl 5:v116-9
D'Addario G, Früh Martin, Reck M, Baumann P, Klepetko W, Felip E, ESMO Guidelines Working Group
Low-Dose Fulvestrant Maintained Long-Term Complete Remission after Poor Response to Previous Endocrine Therapies in a Patient with Advanced Breast Cancer
Hawle H, Hess D, Mueller A, Thürlimann B. Low-Dose Fulvestrant Maintained Long-Term Complete Remission after Poor Response to Previous Endocrine Therapies in a Patient with Advanced Breast Cancer. Case Rep Oncol 2010; 3:131-136.
29.04.2010Low-Dose Fulvestrant Maintained Long-Term Complete Remission after Poor Response to Previous Endocrine Therapies in a Patient with Advanced Breast Cancer
29.04.2010Case Rep Oncol 2010; 3:131-136
Hawle H, Hess Dagmar, Mueller A, Thürlimann Beat
Inadequate quality of surveillance after curative surgery for colon cancer
Viehl C, Ochsner A, von Holzen U, Cecini R, Langer I, Gueller U, Laffer U, Oertli D, Zuber M. Inadequate quality of surveillance after curative surgery for colon cancer. Ann Surg Oncol 2010; 17:2663-9.
29.04.2010Inadequate quality of surveillance after curative surgery for colon cancer
29.04.2010Ann Surg Oncol 2010; 17:2663-9
Viehl Carsten T, Ochsner Alex, von Holzen Urs, Cecini Ramona, Langer Igor, Gueller Ulrich, Laffer Urban, Oertli Daniel, Zuber Markus
Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial
Riethdorf S, von Minckwitz G, Untch M, Eidtmann H, Tesch H, Holms F, Hilfrich J, Schrader I, Fehm T, Huober J, Roller M, Komor M, Loibl S, Rau T, Zhang L, Müller V, Pantel K. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin Cancer Res 2010; 16:2634-45.
20.04.2010Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial
20.04.2010Clin Cancer Res 2010; 16:2634-45
Riethdorf Sabine, von Minckwitz Gunter, Untch Michael, Eidtmann Holger, Tesch Hans, Holms Frank, Hilfrich Jörn, Schrader Iris, Fehm Tanja, Huober Jens, Roller Marc, Komor Martina, Loibl Sibylle, Rau Thomas, Zhang Liling, Müller Volkmar, Pantel Klaus
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial
Phillips K, Gelber R, Price K, Goldhirsch A, Coates A, Pagani O, Cardoso F, Thürlimann B, Harvey V, Thompson A, Stephens A, Sun Z, Ribi K, Bernhard J. Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. Breast 2010; 19:388-95.
10.04.2010Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial
10.04.2010Breast 2010; 19:388-95
Phillips Kelly-Anne, Gelber Richard D, Price Karen N, Goldhirsch Aron, Coates Alan S, Pagani Olivia, Cardoso Fatima, Thürlimann Beat, Harvey Vernon, Thompson Alastair, Stephens Alisa, Sun Zhuoxin, Ribi Karin, Bernhard Jürg
Bisphosphonates in adjuvant treatment of early breast cancer
The Scientific Board, Harbeck N, von Minckwitz G, Thürlimann B. Bisphosphonates in adjuvant treatment of early breast cancer. Crit Rev Oncol Hematol 2010; 74S1:S1.
01.04.2010Bisphosphonates in adjuvant treatment of early breast cancer
01.04.2010Crit Rev Oncol Hematol 2010; 74S1:S1
The Scientific Board, Harbeck Nadia, von Minckwitz Gunter, Thürlimann Beat